Skip to content

Frontlight ResearchEarly access

Trial site

Allife Medicine （Beijing） Limitied

Beijing, Beijing Municipality 100053, ChinaNot linked to an institution yet

1closed trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Stroke

Closed trials

Completed
Safety and Preliminary Efficacy of Allogeneic Endothelial Progenitor Cells (EPCs) in Patients With Acute Ischemic Stroke
NCT05993884· Phase 1· Allife Medical Science and Technology Co., Ltd.· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Allife Medicine （Beijing） Limitied: trial site – Frontlight Research